Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Generation of Tumor-reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines

NCT07239544 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Soochow University as lead sponsor.

NCT NCT07239544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07239544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Generation of Tumor-reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines
Lead sponsor
The First Affiliated Hospital of Soochow University
Phase
Observational
Overall status
Active, not recruiting
Start date
July 10, 2025
Completion date
July 10, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer (nsclc)